"Designing Growth Strategies is in our DNA"

Hepatitis C Drug Market Size, Share & Industry Analysis, By Product (NS5A Inhibitor (Protease Inhibitors), Fixed-dose Combination, Others), By Disease Type (Acute Hepatitis C, Chronic Hepatitis C), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2032

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI101562

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Hepatitis C by Key Countries
    2. Pipeline Analysis
    3. Regulatory Scenario by Key Regions
    4. Pricing Analysis
    5. Overview of Genotypes of Hepatitis C by Key Regions
    6. New Product Launches
    7. Key Industry Developments
  5. Global Hepatitis C Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product Type
      1. NS5A Inhibitor (Protease Inhibitors)
      2. Fixed-dose Combination
      3. Others
    3. Market Analysis, Insights and Forecast – By Disease Type
      1. Acute Hepatitis C
      2. Chronic Hepatitis C
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Hepatitis C Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Product Type
      1. NS5A Inhibitor (Protease Inhibitors)
      2. Fixed-dose Combination
      3. Others
    3. Market Analysis – By Disease Type
      1. Acute Hepatitis C
      2. Chronic Hepatitis C
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Hepatitis C Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Product Type
      1. NS5A Inhibitor (Protease Inhibitors)
      2. Fixed-dose Combination
      3. Others
    3. Market Analysis – By Disease Type
      1. Acute Hepatitis C
      2. Chronic Hepatitis C
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Hepatitis C Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Product Type
      1. NS5A Inhibitor (Protease Inhibitors)
      2. Fixed-dose Combination
      3. Others
    3. Market Analysis – By Disease Type
      1. Acute Hepatitis C
      2. Chronic Hepatitis C
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Hepatitis C Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Product Type
      1. NS5A Inhibitor (Protease Inhibitors)
      2. Fixed-dose Combination
      3. Others
    3. Market Analysis – By Disease Type
      1. Acute Hepatitis C
      2. Chronic Hepatitis C
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Hepatitis C Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Product Type
      1. NS5A Inhibitor (Protease Inhibitors)
      2. Fixed-dose Combination
      3. Others
    3. Market Analysis – By Disease Type
      1. Acute Hepatitis C
      2. Chronic Hepatitis C
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ Sub-Region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2018)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. AbbVie Inc.
      2. Gilead Sciences Inc.
      3. Bristol-Myers Squibb Company
      4. Janssen Pharmaceuticals, Inc.
      5. Merck Sharp & Dohme Corp.
      6. F. Hoffmann-La Roche Ltd
      7. Vertex Pharmaceuticals Incorporated
      8. Other Prominent Players
  12. Strategic Recommendations

 

Read Less

Figure 1:  Global Hepatitis C Drugs Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 2:  Global Hepatitis C Drugs Market Value Share (%), by Product, 2018 & 2026

Figure 3:  Global Hepatitis C Drugs Market Forecast (US$ Mn), by NS5A Inhibitor (Protease Inhibitors), 2015-2026

Figure 4:  Global Hepatitis C Drugs Market Forecast (US$ Mn), by Fixed-dose Combination, 2015-2026

Figure 5:  Global Hepatitis C Drugs Market Forecast (US$ Mn), by Others, 2015-2026

Figure 6:  Global Hepatitis C Drugs Market Value Share (%), by Disease Type, 2018 & 2026

Figure 7:  Global Hepatitis C Drugs Market Forecast (US$ Mn), by Acute Hepatitis C, 2015-2026

Figure 8:  Global Hepatitis C Drugs Market Forecast (US$ Mn), by Chronic Hepatitis C, 2015-2026

Figure 9:  Global Hepatitis C Drugs Market Value Share (%), by Distribution Channel, 2018 & 2026

Figure 10:  Global Hepatitis C Drugs Market Forecast (US$ Mn), by Hospital Pharmacies, 2015-2026

Figure 11:  Global Hepatitis C Drugs Market Forecast (US$ Mn), by Retail Pharmacies, 2015-2026

Figure 12:  Global Hepatitis C Drugs Market Forecast (US$ Mn), by Online Pharmacies, 2015-2026

Figure 13:  Global Hepatitis C Drugs Market Forecast (US$ Mn), by Others, 2015-2026

Figure 14:  Global Hepatitis C Drugs Market Value (US$ Mn), by Region, 2018 & 2026

Figure 15:  North America Hepatitis C Drugs Market Value (US$ Mn), by Product, 2018 & 2026

Figure 16:  North America Hepatitis C Drugs Market Value Share (%), by Product, 2018

Figure 17:  North America Hepatitis C Drugs Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 18:  North America Hepatitis C Drugs Market Value Share (%), by Disease Type, 2018

Figure 19:  North America Hepatitis C Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 20:  North America Hepatitis C Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 21:  North America Hepatitis C Drugs Market Value (US$ Mn), By Country, 2018 & 2026

Figure 22:  North America Hepatitis C Drugs Market Value Share (%), By Country, 2018

Figure 23:  Europe Hepatitis C Drugs Market Value (US$ Mn), by Product, 2018 & 2026

Figure 24:  Europe Hepatitis C Drugs Market Value Share (%), by Product, 2018

Figure 25:  Europe Hepatitis C Drugs Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 26:  Europe Hepatitis C Drugs Market Value Share (%), by Disease Type, 2018

Figure 27:  Europe Hepatitis C Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 28:  Europe Hepatitis C Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 29:  Europe Hepatitis C Drugs Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 30:  Europe Hepatitis C Drugs Market Value Share (%), By Country/ Sub-region, 2018

Figure 31:  Asia Pacific Hepatitis C Drugs Market Value (US$ Mn), by Product, 2018 & 2026

Figure 32:  Asia Pacific Hepatitis C Drugs Market Value Share (%), by Product, 2018

Figure 33:  Asia Pacific Hepatitis C Drugs Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 34:  Asia Pacific Hepatitis C Drugs Market Value Share (%), by Disease Type, 2018

Figure 35:  Asia Pacific Hepatitis C Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 36:  Asia Pacific Hepatitis C Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 37:  Asia Pacific Hepatitis C Drugs Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 38:  Asia Pacific Hepatitis C Drugs Market Value Share (%), By Country/ Sub-region, 2018

Figure 39:  Latin America Hepatitis C Drugs Market Value (US$ Mn), by Product, 2018 & 2026

Figure 40:  Latin America Hepatitis C Drugs Market Value Share (%), by Product, 2018

Figure 41:  Latin America Hepatitis C Drugs Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 42:  Latin America Hepatitis C Drugs Market Value Share (%), by Disease Type, 2018

Figure 43:  Latin America Hepatitis C Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 44:  Latin America Hepatitis C Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 45:  Latin America Hepatitis C Drugs Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 46:  Latin America Hepatitis C Drugs Market Value Share (%), By Country/ Sub-region, 2018

Figure 47:  Middle East & Africa Hepatitis C Drugs Market Value (US$ Mn), by Product, 2018 & 2026

Figure 48:  Middle East & Africa Hepatitis C Drugs Market Value Share (%), by Product, 2018

Figure 49:  Middle East & Africa Hepatitis C Drugs Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 50:  Middle East & Africa Hepatitis C Drugs Market Value Share (%), by Disease Type, 2018

Figure 51:  Middle East & Africa Hepatitis C Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 52:  Middle East & Africa Hepatitis C Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 53:  Middle East & Africa Hepatitis C Drugs Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 54:  Middle East & Africa Hepatitis C Drugs Market Value Share (%), By Country/ Sub-region, 2018

Figure 55:  Global Hepatitis C Drugs Market Share (%), By Company, 2018

 

Table 1:  Global Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, by Product, 2015–2026

Table 2:  Global Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, by Disease Type, 2015–2026

Table 3:  Global Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 4:  Global Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, by Region, 2015-2026

Table 5:  North America Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, by Product, 2015-2026

Table 6:  North America Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 7:  North America Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 8:  North America Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, By Country, 2015-2026

Table 9:  Europe Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, by Product, 2015-2026

Table 10:  Europe Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 11:  Europe Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 12:  Europe Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 13:  Asia Pacific Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, by Product, 2015-2026

Table 14:  Asia Pacific Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 15:  Asia Pacific Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 16:  Asia Pacific Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 17:  Latin America Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, by Product, 2015-2026

Table 18:  Latin America Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 19:  Latin America Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 20:  Latin America Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 21:  Middle East & Africa Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, by Product, 2015-2026

Table 22:  Middle East & Africa Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 23:  Middle East & Africa Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 24:  Middle East & Africa Hepatitis C Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Hepatitis C Drug Market Size, Share and Global Industry Trend Forecast till 2032
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Consulting Services
    How will you benefit from our consulting services ?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann